Use of GLP-1 mimetic in type 2 diabetes mellitus: is it the end of fragility fractures?
| Contribuinte(s) |
Remodelage osseux et biomatériaux ; Université d'Angers (UA) - Institut National de la Santé et de la Recherche Médicale (INSERM) |
|---|---|
| Data(s) |
2015
|
| Resumo |
International audience <p>Type 2 diabetes mellitus (T2DM) is an insidious disease characterized by hyperglycemia and hyperinsulinemia. Among all complications of T2DM, bone fractures represent a severe alteration of the quality of life of affected individuals and are cost-effective. One explanation for bone fracture could be linked to other diabetes complications such as retinopathy and neuropathy, which increase the incidence of falls. Another explanation could reside in a direct effect of T2DM on bone resulting in poor “quality” of the bone matrix.[...]</p> |
| Identificador |
hal-01392273 https://hal.archives-ouvertes.fr/hal-01392273 DOI : 10.1007/s12020-014-0461-1 OKINA : ua5554 |
| Idioma(s) |
en |
| Publicador |
HAL CCSD |
| Relação |
info:eu-repo/semantics/altIdentifier/doi/10.1007/s12020-014-0461-1 |
| Fonte |
ISSN: 1559-0100 Endocrine https://hal.archives-ouvertes.fr/hal-01392273 Endocrine, 2015, 48, pp.1-2. <10.1007/s12020-014-0461-1> |
| Palavras-Chave | #[SDV] Life Sciences [q-bio] |
| Tipo |
info:eu-repo/semantics/article Journal articles |
